Drug research

PTC923

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Sephience; Sepiapterin

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Study of PTC923 in Participants With PhenylketonuriaNCT05099640	PTC Therapeutics	Phase 3	Completed	2023-04-03Actual
A Long-Term Safety Study of PTC923 in Participants With PhenylketonuriaNCT05166161	PTC Therapeutics	Phase 3	Completed	2026-07-21Actual

PTC TherapeuticsCompletedPrimary completion: 2023-04-03 · Actual

Trial details

PTC TherapeuticsCompletedPrimary completion: 2026-07-21 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.